Company Filing History:
Years Active: 2025
Title: Dieter Wiedenmayer: Innovator in Plasma Kallikrein Inhibition
Introduction
Dieter Wiedenmayer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds for medical treatments.
Latest Patents
Wiedenmayer holds a patent for "Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors." This patent discloses heteroaromatic carboxamides of a specific formula, along with their pharmaceutically acceptable salts. The compounds are designed for the treatment of diseases that can be influenced by the inhibition of plasma kallikrein.
Career Highlights
Dieter Wiedenmayer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on the development of novel therapeutic agents that address critical health issues.
Collaborations
Wiedenmayer collaborates with Maude Giroud, contributing to the advancement of research and development in their field.
Conclusion
Dieter Wiedenmayer's innovative work in plasma kallikrein inhibition exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to pave the way for new treatment options.